Deep Brain Stimulation Programming for Movement Disorders: Current Concepts and Evidence-Based StrategiesThomas Koeglsperger, Kai Bötzel|Frontiers in Neurology|2019Cited by 229
Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trialJohannes Levin, Johannes Schwarz, Wolfgang H. Oertel et al.|The Lancet Neurology|2019Cited by 126